NxStage Voluntary Sak Recall
Higher levels of endotoxin than NxStage tolerates were found in less than 1% of affected sak lots, so they notified patients who had those lots and issued a voluntary recall. An FDA recall was not required.
Read the full article » | Posted 02-15-2018
Related Articles
- Vantive Invests $1B in ShareSource Remote Monitoring Posted 06-11-2025
- Apply for the ASN Home Dialysis Scholarship 2025-6 Program by May 31, 2025 Posted 05-20-2025
- Vantive is Supporting ASN’s Centers of Excellence in Home Dialysis Program Posted 05-20-2025
- NKF Spring Clinical Meeting Home Dialysis Posters Posted 04-23-2025